Ad is loading...
PRPFX
Price
$62.08
Change
-$0.06 (-0.10%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PRPFX vs RAMHX

Header iconPRPFX vs RAMHX Comparison
Open Charts PRPFX vs RAMHXBanner chart's image
Permanent Portfolio Permanent I
Price$62.08
Change-$0.06 (-0.10%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PRPFX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRPFX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRPFX is a Sell and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. PRPFX (3.6B). RAMHX pays higher dividends than PRPFX: RAMHX (1.84) vs PRPFX (0.61). PRPFX was incepted earlier than RAMHX: PRPFX (42 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. PRPFX (15.26). RAMHX has a lower initial minimum investment than PRPFX: RAMHX (250) vs PRPFX (1000). PRPFX annual gain was more profitable for investors over the last year : 26.10 vs. RAMHX (20.31). PRPFX return over 5 years is better than : 57.37 vs. RAMHX (32.43).
PRPFXRAMHXPRPFX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence42 years10 years-
Gain YTD21.17913.582156%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRA1000N/A-
Net Assets3.6B236B2%
Annual Yield % from dividends0.611.8433%
Returns for 1 year26.1020.31129%
Returns for 3 years22.379.39238%
Returns for 5 years57.3732.43177%
Returns for 10 years53.1246.74114%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings